Serge Bodart, MS

Chief Commercial Officer, IDDI Group

Articles by Serge Bodart, MS

Integrating Technology and Expertise

BySerge Bodart, MS

February 11th 2022

Phase I/II study in cancer patients showcases eClinical effectiveness.

Demystifying Submissions of eCOA Documentation for Ethics Review: Are We Making Submissions More Difficult than Necessary?

ByArt Gertel,Stephen A. Raymond,Susan Vallow,Valdo Arnera,Mabel Crescioni,Olivier Chassany,Serge Bodart, MS,Sonya Eremenco

August 14th 2020

Examining how to optimizing the time and effort of Ethics Committees to efficiently and effectively fulfill their human subjects protection remit.

Latest Updated Articles

Demystifying Submissions of eCOA Documentation for Ethics Review: Are We Making Submissions More Difficult than Necessary?
August 14th 2020

Trending on Applied Clinical Trials Online

Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program

Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work

Breaking the Efficacy Ceiling in IBD and Beyond

ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment

The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research